Skip to main content

Brian J. Lynch

Equibles does not estimate personal net worth.

Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDGL alerts

About Brian J. Lynch

Brian J. Lynch is recorded as General Counsel at Madrigal Pharmaceuticals, Inc. (MDGL). The newest filing on record that lists Brian J. Lynch as General Counsel at Madrigal Pharmaceuticals, Inc. (MDGL) is dated April 29, 2024. The proxy statement of Madrigal Pharmaceuticals, Inc. reports total compensation of $5,266,584 for Brian J. Lynch in fiscal 2023, including a base salary of $501,590. Disclosed compensation is on record for 5 fiscal years. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Madrigal Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Madrigal Pharmaceuticals, Inc. (MDGL) $501,590 $5,266,584
2022 Madrigal Pharmaceuticals, Inc. (MDGL) $467,604 $4,758,149
2021 Madrigal Pharmaceuticals, Inc. (MDGL) $445,333 $3,430,481
2020 Madrigal Pharmaceuticals, Inc. (MDGL) $425,417 $4,447,893
2019 Madrigal Pharmaceuticals, Inc. (MDGL) $358,602 $4,068,637

Recent activity

No call appearances or filed executive changes recorded yet.